| Dataset | Tahoe Therapeutics Tahoe 100M Perturbation Atlas |
| Category | transcriptomics |
| Type | cell type |
| Description | Triamcinolone perturbation in Hs 766T cell line (Tahoe Therapeutics) |
| Similar Terms | |
| Downloads & Tools |
200 genes differentially expressed following the Triamcinolone_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| PLEC | plectin | 0.113318 |
| KRT6A | keratin 6A, type II | 0.0894985 |
| FKBP5 | FK506 binding protein 5 | 0.0725682 |
| ZMYND8 | zinc finger, MYND-type containing 8 | 0.0688235 |
| FTH1 | ferritin, heavy polypeptide 1 | 0.067411 |
| AKAP13 | A kinase (PRKA) anchor protein 13 | 0.0566684 |
| MYOF | myoferlin | 0.0495784 |
| MACF1 | microtubule-actin crosslinking factor 1 | 0.0493997 |
| CUL4B | cullin 4B | 0.0480359 |
| ESYT2 | extended synaptotagmin-like protein 2 | 0.0430474 |
| INTS6 | integrator complex subunit 6 | 0.0430133 |
| SRRM2 | serine/arginine repetitive matrix 2 | 0.0406026 |
| ABLIM3 | actin binding LIM protein family, member 3 | 0.0376705 |
| TGM2 | transglutaminase 2 | 0.0375222 |
| HMGA2 | high mobility group AT-hook 2 | 0.0352461 |
| YAP1 | Yes-associated protein 1 | 0.0346617 |
| LMO7 | LIM domain 7 | 0.0345542 |
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.0343098 |
| P4HA1 | prolyl 4-hydroxylase, alpha polypeptide I | 0.0341151 |
| APLP2 | amyloid beta (A4) precursor-like protein 2 | 0.0333391 |
| EFNB2 | ephrin-B2 | 0.0329263 |
| ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.0327952 |
| SOD2 | superoxide dismutase 2, mitochondrial | 0.0324676 |
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.0321992 |
| VEGFA | vascular endothelial growth factor A | 0.0321812 |
| EFNA5 | ephrin-A5 | 0.0315711 |
| CEP250 | centrosomal protein 250kDa | 0.0313442 |
| NCOA3 | nuclear receptor coactivator 3 | 0.0306921 |
| MSN | moesin | 0.030628 |
| HIVEP2 | human immunodeficiency virus type I enhancer binding protein 2 | 0.0304926 |
| STC1 | stanniocalcin 1 | 0.0298283 |
| HLA-E | major histocompatibility complex, class I, E | 0.0297446 |
| MYH9 | myosin, heavy chain 9, non-muscle | 0.0290177 |
| SQSTM1 | sequestosome 1 | 0.0273393 |
| CTTN | cortactin | 0.0266467 |
| SPINK5 | serine peptidase inhibitor, Kazal type 5 | 0.0262949 |
| HIPK3 | homeodomain interacting protein kinase 3 | 0.0262799 |
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.0259943 |
| ETS2 | v-ets avian erythroblastosis virus E26 oncogene homolog 2 | 0.025917 |
| PODXL | podocalyxin-like | 0.0257933 |
| LRRFIP1 | leucine rich repeat (in FLII) interacting protein 1 | 0.025306 |
| KRT14 | keratin 14, type I | 0.0252833 |
| MED13L | mediator complex subunit 13-like | 0.0246998 |
| PCDH1 | protocadherin 1 | 0.0246334 |
| HSPA8 | heat shock 70kDa protein 8 | 0.0242112 |
| BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | 0.0241239 |
| MT1E | metallothionein 1E | 0.0241064 |
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.0240701 |
| CSNK1A1 | casein kinase 1, alpha 1 | 0.0239941 |
| IGF2 | insulin-like growth factor 2 | 0.0239298 |
| EHBP1L1 | EH domain binding protein 1-like 1 | 0.0234317 |
| PITPNC1 | phosphatidylinositol transfer protein, cytoplasmic 1 | 0.02336 |
| TNS4 | tensin 4 | 0.0228083 |
| TPM3 | tropomyosin 3 | 0.0226898 |
| ZKSCAN1 | zinc finger with KRAB and SCAN domains 1 | 0.0226059 |
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.0225981 |
| HIPK2 | homeodomain interacting protein kinase 2 | 0.0223067 |
| EFHD2 | EF-hand domain family, member D2 | 0.0222983 |
| PTK2 | protein tyrosine kinase 2 | 0.0216966 |
| MN1 | meningioma (disrupted in balanced translocation) 1 | 0.0215827 |
| TBC1D8 | TBC1 domain family, member 8 (with GRAM domain) | 0.0215087 |
| SULF2 | sulfatase 2 | 0.0208074 |
| MED15 | mediator complex subunit 15 | 0.0204792 |
| UBC | ubiquitin C | 0.0202949 |
| SEPTIN9 | septin 9 | 0.0201047 |
| CLMB | calcimembrin | 0.0201028 |
| SET | SET nuclear proto-oncogene | 0.0200701 |
| NONO | non-POU domain containing, octamer-binding | 0.0199498 |
| TOP1 | topoisomerase (DNA) I | 0.0199082 |
| DOCK5 | dedicator of cytokinesis 5 | 0.0198853 |
| TMBIM1 | transmembrane BAX inhibitor motif containing 1 | 0.0198139 |
| ENO2 | enolase 2 (gamma, neuronal) | 0.0195795 |
| TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 0.0192703 |
| GLUL | glutamate-ammonia ligase | 0.0191041 |
| UBAP2L | ubiquitin associated protein 2-like | 0.0189979 |
| LCOR | ligand dependent nuclear receptor corepressor | 0.0188959 |
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.0188923 |
| KDM4C | lysine (K)-specific demethylase 4C | 0.0187753 |
| NUMA1 | nuclear mitotic apparatus protein 1 | 0.0185902 |
| FMNL2 | formin-like 2 | 0.0185736 |
| EEF2 | eukaryotic translation elongation factor 2 | 0.0185601 |
| ITSN2 | intersectin 2 | 0.0185308 |
| USP47 | ubiquitin specific peptidase 47 | 0.0185251 |
| PPP1R15A | protein phosphatase 1, regulatory subunit 15A | 0.018479 |
| AGAP1 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 | 0.0183185 |
| RPL3 | ribosomal protein L3 | 0.0182116 |
| SETD5 | SET domain containing 5 | 0.0181985 |
| JPH2 | junctophilin 2 | 0.018062 |
| PARP4 | poly (ADP-ribose) polymerase family, member 4 | 0.0179551 |
| MAP1LC3B | microtubule-associated protein 1 light chain 3 beta | 0.0177901 |
| CYB5R3 | cytochrome b5 reductase 3 | 0.0177837 |
| HM13 | histocompatibility (minor) 13 | 0.0176184 |
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.0175017 |
| AHNAK2 | AHNAK nucleoprotein 2 | 0.0174765 |
| SLCO4A1 | solute carrier organic anion transporter family, member 4A1 | 0.0173197 |
| NECTIN4 | nectin cell adhesion molecule 4 | 0.0172984 |
| SCNN1A | sodium channel, non voltage gated 1 alpha subunit | 0.0172481 |
| ITGB8 | integrin, beta 8 | 0.0170144 |
| PABPC1 | poly(A) binding protein, cytoplasmic 1 | 0.0169364 |
| UBR4 | ubiquitin protein ligase E3 component n-recognin 4 | 0.0169263 |
| Symbol | Name | Standardized Value |
|---|---|---|
| MT2A | metallothionein 2A | -0.189587 |
| IL1RAPL1 | interleukin 1 receptor accessory protein-like 1 | -0.149683 |
| CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | -0.147515 |
| TMSB10 | thymosin beta 10 | -0.127612 |
| TXNIP | thioredoxin interacting protein | -0.105306 |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | -0.0958518 |
| RPS21 | ribosomal protein S21 | -0.0821603 |
| SULF1 | sulfatase 1 | -0.0799686 |
| FLNB | filamin B, beta | -0.0703008 |
| ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | -0.0702418 |
| MT1X | metallothionein 1X | -0.0646957 |
| PHLDB2 | pleckstrin homology-like domain, family B, member 2 | -0.0576415 |
| ASPH | aspartate beta-hydroxylase | -0.0554807 |
| RPLP2 | ribosomal protein, large, P2 | -0.0511764 |
| DDX60L | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like | -0.0506083 |
| DPYD | dihydropyrimidine dehydrogenase | -0.0469269 |
| RPLP1 | ribosomal protein, large, P1 | -0.0439012 |
| ANXA2 | annexin A2 | -0.0425083 |
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | -0.0422137 |
| RPS19 | ribosomal protein S19 | -0.0417281 |
| CD44 | CD44 molecule (Indian blood group) | -0.0413354 |
| ARHGAP29 | Rho GTPase activating protein 29 | -0.0408366 |
| RPL12 | ribosomal protein L12 | -0.0407022 |
| HSP90B1 | heat shock protein 90kDa beta (Grp94), member 1 | -0.0398151 |
| TMSB4X | thymosin beta 4, X-linked | -0.0396021 |
| NRG1 | neuregulin 1 | -0.0390713 |
| HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | -0.038984 |
| HERC4 | HECT and RLD domain containing E3 ubiquitin protein ligase 4 | -0.0386034 |
| NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | -0.0374846 |
| HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | -0.0373425 |
| IFI16 | interferon, gamma-inducible protein 16 | -0.035923 |
| ERC2 | ELKS/RAB6-interacting/CAST family member 2 | -0.0353417 |
| VCL | vinculin | -0.0351486 |
| PALLD | palladin, cytoskeletal associated protein | -0.0349646 |
| NAMPT | nicotinamide phosphoribosyltransferase | -0.0342628 |
| MAML2 | mastermind-like 2 (Drosophila) | -0.0342228 |
| KMT2E | lysine (K)-specific methyltransferase 2E | -0.0341611 |
| S100A10 | S100 calcium binding protein A10 | -0.0338238 |
| SLC25A5 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | -0.0336601 |
| POTEF | POTE ankyrin domain family, member F | -0.0334551 |
| RPL8 | ribosomal protein L8 | -0.0327062 |
| S100A4 | S100 calcium binding protein A4 | -0.0322803 |
| OSMR | oncostatin M receptor | -0.0313844 |
| RAP1B | RAP1B, member of RAS oncogene family | -0.0312187 |
| NT5C2 | 5'-nucleotidase, cytosolic II | -0.0309819 |
| RPL11 | ribosomal protein L11 | -0.0307352 |
| PLAT | plasminogen activator, tissue | -0.030724 |
| NAP1L1 | nucleosome assembly protein 1-like 1 | -0.0303601 |
| PSD3 | pleckstrin and Sec7 domain containing 3 | -0.0300241 |
| SLCO1B3 | solute carrier organic anion transporter family, member 1B3 | -0.0299246 |
| LMNA | lamin A/C | -0.0297167 |
| IFITM3 | interferon induced transmembrane protein 3 | -0.0292875 |
| SH3BGRL3 | SH3 domain binding glutamate-rich protein like 3 | -0.0291492 |
| NEK7 | NIMA-related kinase 7 | -0.0290802 |
| ALDH3A1 | aldehyde dehydrogenase 3 family, member A1 | -0.0290294 |
| SLC38A2 | solute carrier family 38, member 2 | -0.028893 |
| RPS6 | ribosomal protein S6 | -0.0288116 |
| RIN2 | Ras and Rab interactor 2 | -0.0286891 |
| FOXP1 | forkhead box P1 | -0.0284615 |
| FOXO1 | forkhead box O1 | -0.0276402 |
| ARL6IP1 | ADP-ribosylation factor-like 6 interacting protein 1 | -0.027192 |
| SLC25A37 | solute carrier family 25 (mitochondrial iron transporter), member 37 | -0.0271002 |
| RPS24 | ribosomal protein S24 | -0.0270712 |
| MARCKS | myristoylated alanine-rich protein kinase C substrate | -0.0267525 |
| YBX3 | Y box binding protein 3 | -0.0265962 |
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | -0.0265336 |
| MYO10 | myosin X | -0.0263486 |
| DDAH1 | dimethylarginine dimethylaminohydrolase 1 | -0.0263198 |
| PALM2AKAP2 | PALM2 and AKAP2 fusion | -0.0258135 |
| S100A6 | S100 calcium binding protein A6 | -0.0255494 |
| RPL32 | ribosomal protein L32 | -0.0253107 |
| EIF1 | eukaryotic translation initiation factor 1 | -0.0248966 |
| NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | -0.0241596 |
| CBFA2T2 | core-binding factor, runt domain, alpha subunit 2; translocated to, 2 | -0.0239731 |
| LOC112694756 | uncharaterized LOC112694756 | -0.0239302 |
| ANLN | anillin, actin binding protein | -0.023588 |
| THBD | thrombomodulin | -0.0235389 |
| TM4SF1 | transmembrane 4 L six family member 1 | -0.0232612 |
| RPS4X | ribosomal protein S4, X-linked | -0.0231981 |
| H1-0 | H1.0 linker histone | -0.0230793 |
| RPL35 | ribosomal protein L35 | -0.0230608 |
| LMAN1 | lectin, mannose-binding, 1 | -0.0228095 |
| CLINT1 | clathrin interactor 1 | -0.0227308 |
| ITGA6 | integrin, alpha 6 | -0.0227285 |
| COX4I1 | cytochrome c oxidase subunit IV isoform 1 | -0.0226751 |
| KIAA1217 | KIAA1217 | -0.022666 |
| ACTN4 | actinin, alpha 4 | -0.0226377 |
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | -0.0225135 |
| NRIP1 | nuclear receptor interacting protein 1 | -0.0224462 |
| ENO1 | enolase 1, (alpha) | -0.0224 |
| RPL5 | ribosomal protein L5 | -0.0222196 |
| CNRIP1 | cannabinoid receptor interacting protein 1 | -0.0219339 |
| DCBLD2 | discoidin, CUB and LCCL domain containing 2 | -0.0218917 |
| S100A9 | S100 calcium binding protein A9 | -0.021842 |
| MECOM | MDS1 and EVI1 complex locus | -0.021813 |
| PRSS23 | protease, serine, 23 | -0.0218037 |
| GARS1 | glycyl-tRNA synthetase 1 | -0.0218033 |
| GPRC5A | G protein-coupled receptor, class C, group 5, member A | -0.0217724 |
| CDK6 | cyclin-dependent kinase 6 | -0.0216096 |
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | -0.0216008 |
